NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization168.55 mln
Float26.15 mln
Earnings Date08/10/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.74
Highly reliable
1-Year Forecast
20.60
Transformational upside
Relative Strength
8
/ 100
Severely lagging
Debt / Equity
0.12
Very low leverage
ROE
-35.93
Deeply negative
Business Description
Arcturus Therapeutics is a San Diego-based medicine company founded in 2013 that uses mRNA technology to create treatments for rare liver and respiratory diseases, as well as vaccines for infectious illnesses like COVID-19 and influenza. The company has developed its own delivery system to get these medicines into the body effectively, and several of its treatments are currently being tested in clinical trials. Its most advanced programs target cystic fibrosis and a rare liver disorder that prevents the body from processing certain proteins.
